Merck & Co. will price its Zocor cholesterol pill below Teva Pharmaceutical Industries Ltd.'s generic version, an unprecedented move by the drugmaker to salvage sales of its best-selling product ...

But, if successful, this drug has the potential to indeed become the PCSK9 inhibitor for the masses. It could bring Merck full circle back to the days of Mevacor and Zocor.

Aetna Inc. said Thursday that it would buy discounted copies of the cholesterol drug Zocor from Teva Pharmaceutical Industries Ltd. rather than accept an offer from Merck & Co. to sell its branded ...

Business; With Merck patient studies in doubt, 2 analysts downgrade drugmaker's rating. Published: Feb. 04, 2013, 10:00 p.m. Feb. 04, 2013, 10:00 p.m.

2008 STAR-LEDGER FILE PHOTOVytorin, a cholesterol drug manufactured by Merck that combines Zocor and Zetia. WHITEHOUSE STATION -- Merck & Co. and its Schering unit sued Teva Pharmaceutical ...

Merck is implementing an aggressive price control plan for cholesterol treatment Zocor (simvastatin) to hang on to market share following the drug’s loss of patent protection Friday.A spokesman from ...

With Merck & Co.'s Zocor facing generic competition tomorrow, the drug maker has decided to sell its cholesterol-fighting drug to some major managed-care companies at what is expected to be a ...

NEW YORK — It’s a novel approach in the long battle between brand-name drugs and their generic rivals: Merck & Co. is slashing the price of its cholesterol drug Zocor so low for one insurance ...

June 20, 2006 — -- This Friday, Merck's patent on the cholesterol - lowering drug Zocor will expire. There will now be a generic version of the drug for sale called Simvastatin.